يعرض 1 - 10 نتائج من 20 نتيجة بحث عن '"Kevin Wojta"', وقت الاستعلام: 1.03s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: Ayer, Ariane H, Wojta, Kevin, Ramos, Eliana Marisa, Dokuru, Deepika, Chen, Jason A, Karydas, Anna M, Papatriantafyllou, John D, Agiomyrgiannakis, Dimitrio, Kamtsadeli, Vasiliki, Tsinia, Niki, Sali, Dimitra, Gylys, Karen H, Agosta, Federica, Filippi, Massimo, Small, Gary W, Bennett, David A, Gearing, Marla, Juncos, Jorge L, Kramer, Joel, Lee, Suzee E, Yokoyama, Jennifer S, Mendez, Mario F, Chui, Helena, Zarow, Chri, Ringman, John M, Kilic, Ulkan, Babacan-Yildiz, Gülsen, Levey, Allan, Decarli, Charles S, Cotman, Carl W, Boxer, Adam L, Miller, Bruce L, Coppola, Giovanni, BABACAN YILDIZ, GÜLSEN

    المصدر: Alzheimer disease and associated disorders, vol 33, iss 4
    Alzheimer Dis Assoc Disord

    مصطلحات موضوعية: Male, Oncology, Aging, amyotrophic lateral sclerosis, Internationality, Disease, Neurodegenerative, Alzheimer's Disease, frontotemporal dementia, Cohort Studies, 0302 clinical medicine, Immunologic, Receptors, TREM2, 2.1 Biological and endogenous factors, genetics, 030212 general & internal medicine, Receptors, Immunologic, Ayer A., Wojta K., Ramos E., Dokuru D., Chen J., Karydas A., Papatriantafyllou J., Agiomyrgiannakis D., Kamtsadeli V., Tsinia N., et al., -Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.-, Alzheimer disease and associated disorders, cilt.33, ss.327-330, 2019, Aetiology, Amyotrophic lateral sclerosis, Membrane Glycoproteins, Neurodegenerative Diseases, Psychiatry and Mental health, Clinical Psychology, Frontotemporal Dementia, Neurological, Cohort, Female, Cognitive Sciences, Alzheimer's disease, Frontotemporal dementia, Cohort study, medicine.medical_specialty, Genotype, Clinical Sciences, association study, Article, Progressive supranuclear palsy, 03 medical and health sciences, Rare Diseases, mild cognitive impairment, Alzheimer Disease, Clinical Research, Internal medicine, Acquired Cognitive Impairment, medicine, Humans, Genetic Predisposition to Disease, Cognitive Dysfunction, Aged, business.industry, Amyotrophic Lateral Sclerosis, Neurosciences, Genetic Variation, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), progressive supranuclear palsy, corticobasal syndrome, medicine.disease, Brain Disorders, Geriatrics, Dementia, Geriatrics and Gerontology, business, Gerontology, 030217 neurology & neurosurgery

    وصف الملف: application/pdf

  6. 6
  7. 7
  8. 8

    المساهمون: ARTFL LEFFTDS Consortium

    المصدر: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1
    Alzheimers Dement
    Alzheimer's & dementia

  9. 9
  10. 10

    المساهمون: University of California [Los Angeles] (UCLA), University of California (UC), King‘s College London, Laboratoire de Biostatistique, Epidémiologie clinique, Santé Publique Innovation et Méthodologie [CHU Nîmes] (BESPIM), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université Pierre et Marie Curie - Paris 6 (UPMC), University of Sussex, Queen Mary University of London (QMUL), Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 (RID-AGE), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Universität Ulm - Ulm University [Ulm, Allemagne], This work was funded by grants from the Tau Consortium (D.H.G. and G.C.), the National Institutes of Health, F31 NS084556 (J.A.C.) UG3 NS104095 and P30 NS062691 from the National Institute of Neurological Disorders and Stroke (Informatics Center for Neurogenetics and Neurogenomics to G.C.), and the Fu-Hsing and Jyu-Yuan Chen family. Z.C. was supported by funding from the NIHR Academic Clinical Fellowship. Three academic institutions (Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Assistance Publique-Hôpitaux de Paris and University of Ulm) were sponsors of the NNIPPS study in each country, and jointly own the data. The BBBIPPS study was supported by the French Health Ministry, Programme Hospitalier de Recherche Clinique (AOM04035). The Assistance Publique - Hôpitaux de Paris (France) was the sponsor of the study. The protocol and amendments were reviewed and approved by the Comité de Protection des Personnes of Pitié-Salpêtrière Hospital (France). The NNIPPS genotyping and analysis was supported under the aegis of JPND – (www.jpnd.eu, United Kingdom), Medical Research Council (MR/L501529/1, MR/R024804/1) and Economic and Social Research Council (ES/L008238/1). A.A.C. receives salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The work leading up to this publication was funded by the European Community’s Health Seventh Framework Programme (FP7/2007–2013, grant agreement number 259867) and Horizon 2020 Programme (H2020-PHC-2014-two-stage, grant agreement number 633413). We thank the UCLA Neuroscience Genomics Core​ (www.semel.ucla.edu/ungc) for assistance with genotyping data generation. Samples from the National Cell Repository for Alzheimer’s Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG021886) awarded by the National Institute on Aging (NIA), were used in this study. We thank contributors who collected samples used in this study, as well as patients and their families, whose help and participation made this work possible., European Project: 259867,EC:FP7:HEALTH,FP7-HEALTH-2010-two-stage,EURO-MOTOR(2011), European Project: 633413,H2020,H2020-PHC-2014-two-stage,MIROCALS(2015), University of California, Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

    المصدر: Molecular Neurodegeneration, Vol 13, Iss 1, Pp 1-11 (2018)
    Molecular Neurodegeneration
    Molecular Neurodegeneration, 2018, 13 (1), pp.41. ⟨10.1186/s13024-018-0270-8⟩
    Molecular Neurodegeneration, BioMed Central, 2018, 13 (1), pp.41. ⟨10.1186/s13024-018-0270-8⟩
    Molecular neurodegeneration, vol 13, iss 1
    Chen, J A, Chen, Z, Won, H, Huang, A Y, Lowe, J K, Wojta, K, Yokoyama, J S, Bensimon, G, Leigh, P N, Payan, C, Shatunov, A, Jones, A R, Lewis, C M, Deloukas, P, Amouyel, P, Tzourio, C, Dartigues, J F, Ludolph, A, Boxer, A L, Bronstein, J M, Al-Chalabi, A, Geschwind, D H & Coppola, G 2018, ' Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases ', Molecular Neurodegeneration, vol. 13, no. 1, 41 . https://doi.org/10.1186/s13024-018-0270-8

    وصف الملف: application/pdf